Incruse Ellipta® is approved for
a. exacerbation of chronic obstructive pulmonary disease (COPD).
b. thinning of dried secretions.
c. acute bronchoconstriction.
d. maintenance treatment of airflow obstruction in COPD.
ANS: D
You might also like to view...
Researching the practice's strengths and weaknesses involves:
A) asking the administrative staff if they like working at the practice. B) interviewing clinical staff to determine their equipment preferences. C) taking a broader look at the surrounding community. D) interviewing the nursing staff.
When palpating the body, it is important to feel for _______
a. trigger points b. adhesions c. the myofascial layers d. All of the above e. None of the above
The cell nucleus contains _______________, which are threadlike structures made up of DNA.
Fill in the blank(s) with the appropriate word(s).
If there are no patients in a specific location list area, what happens to that specific location heading?
A. It is deleted from SpringCharts B. The heading is displayed in orange. C. It is not displayed in the Patient Tracker window. D. There are always patients in every location.